51
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Synthesis and HDAC1 Inhibitory Activity of a Novel Series of Coumarin-Based Amide Derivatives for Treatment of Cancer

, ORCID Icon, ORCID Icon, , ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1669-1685 | Received 05 Apr 2023, Accepted 18 Aug 2023, Published online: 21 Sep 2023

References

  • Pant K , PeixotoE , RichardS , GradiloneSA. Role of histone deacetylases in carcinogenesis: potential role in cholangiocarcinoma. Cells9(3), 780 (2020).
  • Ferrarelli LK . HDAC inhibitors in solid tumors and blood cancers. Sci. Signal.9(446), ec216–ec216 (2016).
  • Zheng L , ZhangA , LiuJ , LiuM , ZhangY. HDAC1 promotes the migration of human myeloma cells via regulation of the lncRNA/Slug axis. Int. J. Mol. Med.49(1), 1–9 (2022).
  • Cao L-L , SongX , PeiL , LiuL , WangH , JiaM.Histone deacetylase HDAC1 expression correlates with the progression and prognosis of lung cancer: a meta-analysis. Medicine (Baltimore)96(31), e7663 (2017).
  • Zhang J , GaoX , YuL. Roles of histone deacetylases in acute myeloid leukemia with fusion proteins. Front. Oncol.11, 741746 (2021).
  • Eckschlager T , PlchJ , StiborovaM , HrabetaJ. Histone deacetylase inhibitors as anticancer drugs. Int. J. Mol. Sci.18(7), 1414 (2017).
  • Tasneem S , AlamMM , AmirMet al. Heterocyclic moieties as HDAC inhibitors: role in cancer therapeutics. Mini Rev. Med. Chem.22(12), 1648–1706 (2022).
  • Suraweera A , O'ByrneKJ , RichardDJ. Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi. Front. Oncol.8, 92 (2018).
  • Abdizadeh T , KalaniMR , AbnousKet al. Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents. Eur. J. Med. Chem.132, 42–62 (2017).
  • Tan S , HeF , KongT , WuJ , LiuZ. Design, synthesis and tumor cell growth inhibitory activity of 3-nitro-2H-cheromene derivatives as histone deacetylaes inhibitors. Bioorg. Med. Chem.25(15), 4123–4132 (2017).
  • Jabbar SS , MohammedMH. Design, synthesis, insilco study and biological evaluation of new coumarin-oxadiazole derivatives as potent histone deacetylase inhibitors. Egypt. J. Chem.66(2), 385–393 (2023).
  • Zhu S , ZhuW , LuLet al. Development of the novel HDAC inhibitor ZN444B as a promising treatment for breast cancer. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4403976.
  • Ruwizhi N , AderibigbeBA. cinnamon acid derivatives and their biological efficacy. Int. J. Mol. Sci.21(16), 5712 (2020).
  • De P , BaltasM , Bedos-BelvalF. cinnamon acid derivatives as anticancer agent – a review. Curr. Med. Chem.18(11), 1672–1703 (2011).
  • Garnock-Jones KP . Panobinostat: first global approval. Drugs75, 695–704 (2015).
  • Chen C , HouX , WangGet al. Design, synthesis and biological evaluation of quinoline derivatives as HDAC class I inhibitors. Eur. J. Med. Chem.133, 11–23 (2017).
  • Hieu DT , AnhDT , TuanNMet al. Design, synthesis and evaluation of novel N-hydroxybenzamides/N-hydroxypropenamides incorporating quinazolin-4 (3H)-ones as histone deacetylase inhibitors and antitumor agents. Bioorg. Chem.76, 258–267 (2018).
  • Zhou Y , DunY , FuHet al. Design, synthesis, and preliminary bioactivity evaluation of N-benzylpyrimidin-2-amine derivatives as novel histone deacetylase inhibitor. Chem. Biol. Drug Des.90(5), 936–942 (2017).
  • Yu C , HeF , QuYet al. Structure optimization and preliminary bioactivity evaluation of N-hydroxybenzamide-based HDAC inhibitors with Y-shaped cap. Bioorg. Med. Chem.26(8), 1859–1868 (2018).
  • Zhang Q-W , LiJ-Q. Synthesis and biological evaluation of N-(aminopyridine) benzamide analogues as histone deacetylase inhibitors. Bull. Korean Chem. Soc.33(2), 535–540 (2012).
  • Furniss BS , HannafordAJ , SmithPWG , TatchellAR. Vogel's Textbook of Practical Organic Chemistry (5th Edition).Longman Group UK Limited, London, England (1989).
  • Holbeck SL , CollinsJM , DoroshowJH. Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines. Mol. Cancer Ther.9(5), 1451–1460 (2010).
  • Kavaliauskas P , ŽukauskasŠ , AnusevičiusKet al. A N-(4-chlorophenyl)-γ-amino acid derivatives exerts in vitro anticancer activity on non-small cell lung carcinoma cells and enhances citosine arabinoside (AraC)-induced cell death via mitochondria-targeted pathway. Results Chem.3, 100193 (2021).
  • Sharma Y , BashirS , KhanMF , AhmadA , KhanF. Inhibition of Src homology 2 domain containing protein tyrosine phosphatase as the possible mechanism of metformin-assisted amelioration of obesity induced insulin resistance in high fat diet fed C57BL/6J mice. Biochem. Biophys. Res. Commun.487(1), 54–61 (2017).
  • Khan MF , VermaG , AkhtarWet al. Pharmacophore modeling, 3D-QSAR, docking study and ADME prediction of acyl 1, 3, 4-thiadiazole amides and sulfonamides as antitubulin agents. Arab. J. Chem.12(8), 5000–5018 (2019).
  • Ntie-Kang F . An in silico evaluation of the ADMET profile of the StreptomeDB database. Springerplus2, 1–11 (2013).
  • Heravi MM , KhaghaninejadS , MostofiM.Pechmann reaction in the synthesis of coumarin derivatives. In: Advances in Heterocyclic Chemistry.KatritzkyAR ( Ed.). Elsevier, Norwich, UK, 1–50 (2014).
  • Zhou X , FranklinRA , AdlerMet al. Circuit design features of a stable two-cell system. Cell172(4), 744–757 (2018).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.